Anima Biotech Announces Preclinical Data of Candidate in Idiopathic Pulmonary Fibrosis

BERNARDSVILLE, N.J., Feb. 07, 2024 (GLOBE NEWSWIRE) -- Anima Biotech, the Tech.Bio leader bringing AI to mRNA biology, announced today positive preclinical data of its lung fibrosis candidate. This drug operates through a novel mRNA biology mechanism of action, opening new avenues for treating…#bernardsville #animabiotech #ipf #lightningplatform #anima #admet #yochislonim #abbvie #elililly #immunologyoncology
Source: Reuters: Health - Category: Consumer Health News Source Type: news